XML 67 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Instruments
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Financial Instruments Financial Instruments

A summary of assets and (liabilities) as of December 31, 2019 and 2018 related to our financial instruments, measured at fair value on a recurring basis and as reflected in our consolidated balance sheets, is set forth below:
 
 
Balance as of December 31, 2019
 
Quoted Prices in Active Markets for Identical Assets
 (Level 1)
 
Significant
Other Observable Inputs
(Level 2)
 
Significant
Unobservable Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
 
Cash equivalents
 
 
 
 
 
 
 
 
        Money market funds
 
$
221,442

 
$
221,442

 
$

 
$

Short-term investments
 
 
 
 
 
 
 
 
   U.S. treasury securities
 
70,029

 
70,029

 

 

Loans held for sale
 
21,985

 

 
21,985

 

Prepaid expenses and other current assets
 
 
 
 
 
 
 
 
Forward sales commitments
 
4

 

 
4

 

Interest rate lock commitments
 
496

 

 

 
496

Total prepaid expenses and other current assets
 
500

 

 
4

 
496

Long-term investments
 
 
 
 
 
 
 
 
   U.S. treasury securities
 
30,978

 
30,978

 

 

Total assets
 
$
344,934

 
$
322,449


$
21,989

 
$
496

Liabilities
 
 
 
 
 
 
 
 
Accrued liabilities
 
 
 
 
 
 
 
 
Forward sales commitments
 
$
57

 
$

 
$
57

 
$

Interest rate lock commitments
 
58

 

 

 
58

Total liabilities
 
$
115

 
$

 
$
57

 
$
58


 
 
Balance as of December 31, 2018
 
Quoted Prices in Active Markets for Identical Assets
 (Level 1)
 
Significant
Other Observable Inputs
(Level 2)
 
Significant
Unobservable Inputs
(Level 3)
Assets
 
 
 
 
 
 
 
 
Cash equivalents
 
 
 
 
 
 
 
 
        Money market funds
 
$
425,776

 
$
425,776

 
$

 
$

Loans held for sale
 
4,913

 

 
4,913

 

Prepaid expenses and other current assets
 
 
 
 
 
 
 
 
Interest rate lock commitments
 
254

 

 

 
254

Total prepaid expenses and other current assets
 
254

 

 

 
254

Total assets
 
$
430,943

 
$
425,776

 
$
4,913

 
$
254

Liabilities
 
 
 
 
 
 
 
 
Accrued liabilities
 
 
 
 
 
 
 
 
Forward sales commitments
 
$
141

 
$

 
$
141

 
$

Total liabilities
 
$
141

 
$

 
$
141

 
$


There was no significant activity within Level 3 financial instruments during the periods presented.

See Note 14 for the carrying amount and estimated fair value of our convertible senior notes.

Assets and liabilities recognized or disclosed at fair value on a nonrecurring basis include items such as property and equipment, goodwill and other intangible assets, cost method investments, and other assets. These assets are measured at fair value if determined to be impaired. We did not record any significant nonrecurring fair value measurements after initial recognition for the year ended December 31, 2019.

The following table summarizes the cost or amortized cost, gross unrealized gains and losses, and estimated fair market value of our cash, money market funds, restricted cash and available-for-sale investments as of December 31, 2019 and 2018:
 
 
December 31, 2019
 
 
Fair Value Hierarchy
 
Cost or Amortized Cost
 
Unrealized Gains
 
Unrealized Losses
 
Estimated Fair Value
 
Short-term Investments
 
Long-term Investments
Cash
 
N/A
 
13,237

 

 

 
13,237

 

 

Money markets funds
 
Level 1
 
221,442

 

 

 
221,442

 

 

Restricted cash
 
N/A
 
12,769

 

 

 
12,769

 

 

U.S. treasury securities
 
Level 1
 
100,998

 
31

 
(22
)
 
101,007

 
70,029

 
30,978

Total
 
 
 
348,446

 
31

 
(22
)
 
348,455

 
70,029

 
30,978


 
 
December 31, 2018
 
 
Fair Value Hierarchy
 
Cost or Amortized Cost
 
Unrealized Gains
 
Unrealized Losses
 
Estimated Fair Value
 
Short-term Investments
 
Long-term Investments
Cash
 
N/A
 
6,832

 

 

 
6,832

 

 

Money markets funds
 
Level 1
 
425,776

 

 

 
425,776

 

 

Restricted cash
 
N/A
 
6,446

 

 

 
6,446

 

 

Total
 
 
 
439,054

 

 

 
439,054

 

 



There were no other than temporary impairments during the periods presented.